CETP inhibitors

Details for Australian Patent Application No. 2006335108 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Chen, Yi-Heng; Ali, Amjad; Thompson, Christopher F.; Li, Hong; Lu, Zhijian; Smith, Cameron J.; Sinclair, Peter J.

Agent Spruson & Ferguson

Pub. Number AU-B-2006335108

PCT Pub. Number WO2007/081569

Priority 60/755,541 30.12.05 US

Filing date 29 December 2006

Wipo publication date 19 July 2007

Acceptance publication date 7 April 2011

International Classifications

C07D 403/02 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/421 (2006.01) - 1,3-Oxazoles, e.g. pemoline, trimethadione

A61K 31/4439 (2006.01)

C07D 263/16 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

Event Publications

3 July 2008 PCT application entered the National Phase

  PCT publication WO2007/081569 Priority application(s): WO2007/081569

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

7 April 2011 Application Accepted

  Published as AU-B-2006335108

4 August 2011 Standard Patent Sealed

11 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006335109-Cholesteryl ester transfer protein inhibitors

2006335104-Ammonia sensor and system for use